Janus Kinase Inhibitor [EPC]: Side Effects & Safety Data for 5 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Janus Kinase Inhibitor [EPC] includes 5 drugs with a combined 300,714 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
5
Drugs in Class
300,714
Combined Reports
All Janus Kinase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| TOFACITINIB | XELJANZ XR | 155,647 | 7,847 | 21,976 | 5.0% |
| RUXOLITINIB | OPZELURA | 68,133 | 10,908 | 14,461 | 16.0% |
| UPADACITINIB | Rinvoq | 65,656 | 2,406 | 15,931 | 3.7% |
| BARICITINIB | Olumiant | 8,108 | 717 | 2,498 | 8.8% |
| ABROCITINIB | CIBINQO | 3,170 | 57 | 329 | 1.8% |
Common Side Effects in Janus Kinase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 36,486 | 1,697 |
| Pain | 28,105 | 1,900 |
| Off label use | 26,140 | 3,385 |
| Fatigue | 21,585 | 2,025 |
| Arthralgia | 20,862 | 1,624 |
| Condition aggravated | 18,910 | 1,659 |
| Rheumatoid arthritis | 15,330 | 1,775 |
| Headache | 15,207 | 1,496 |
| Pain in extremity | 12,344 | 1,099 |
| Joint swelling | 12,136 | 1,802 |